Kozak & Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100
Closed -$12.6K 403
2023
Q4
$12.6K Hold
100
﹤0.01% 216
2023
Q3
$16K Hold
100
0.01% 205
2023
Q2
$22.9K Hold
100
0.01% 185
2023
Q1
$22.1K Hold
100
0.01% 192
2022
Q4
$22K Hold
100
0.01% 188
2022
Q3
$27K Hold
100
0.02% 173
2022
Q2
$21K Hold
100
0.01% 196
2022
Q1
$19K Hold
100
0.01% 212
2021
Q4
$19K Hold
100
0.01% 212
2021
Q3
$27K Buy
+100
New +$21.4K 0.02% 192

Other funds holding ALB

Kozak & Associates's ALB Position: Q1 2024 in Review

Kozak & Associates sold out of Albemarle (ALB) in Q1 2024, closing a stake of 100 shares — an estimated $12.6K sold.

Kozak & Associates first reported a position in ALB in Q3 2021 and held it in 10 quarters. The position peaked at $27K in Q3 2022. 916 funds tracked by Wall St. Rank hold ALB as of Q1 2024.

  • Kozak & Associates reported no remaining Albemarle position as of Q1 2024 after selling out during the quarter.
  • Kozak & Associates sold 100 Albemarle shares in Q1 2024, an estimated $12.6K.
  • Kozak & Associates first reported a position in Albemarle in Q3 2021 and held it in 10 quarters.
  • Kozak & Associates's Albemarle position peaked at $27K in Q3 2022.
  • 916 funds tracked by Wall St. Rank held Albemarle as of Q1 2024.

Based on Kozak & Associates's 13F filing for Q1 2024, filed 17 May 2024.